drug · antibody
toripalimab
Phase 2updated 5mo agoby $CHRS Coherus Oncology, Inc.🔗 ChEMBL
Phase 2community read0 votes
🐶 often sniffed alongside
top 3Antibody drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 52 investigational indications.
indications
indications
Melanoma
targets
Programmed cell death protein 1
all catalysts(1)
Trials studying toripalimab
- phase2A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer.
- phase2Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors
- phase2A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tumors
- phase2Toripalimab With Chemotherapy for Sinus Cancer
- phase2STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
- EP1An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors
- phase4A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
- phase2Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that